Grant Harmon, MD | |
510 Sw Ramsey Ave, Grants Pass, OR 97527-5554 | |
(541) 789-4673 | |
Not Available |
Full Name | Grant Harmon |
---|---|
Gender | Male |
Speciality | Radiation Oncology |
Experience | 7 Years |
Location | 510 Sw Ramsey Ave, Grants Pass, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639606379 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Asante Rogue Regional Medical Center | Medford, OR | Hospital |
Asante Three Rivers Medical Center | Grants pass, OR | Hospital |
Loyola University Medical Center | Maywood, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Radiation Oncology Group Consultants P C | 0446248405 | 6 |
News Archive
Idera Pharmaceuticals, Inc. today announced the publication of data from studies of a dual agonist of Toll-like Receptor 7 and TLR8 in preclinical models of cancer. The Company created this first-in-class RNA-based dual agonist of TLR7 and TLR8 through its chemistry-based approach to identifying novel TLR-targeted drug candidates.
Piramal's Healthcare vertical today announced that it is to invest USD 2.5 million at its FDA approved Grangemouth, UK, site to upgrade one of its antibody drug conjugate (ADC) manufacturing suites, from clinical phase to commercial grade, in response to customer demand.
Worldwide, there are over 3 million stillbirths and approximately 3 million newborn deaths each year, most in low-resource countries.
Decisions, decisions, decisions. Wouldn't it be nice to have a computer program that could help you make work-related decisions? That's exactly what Drs. Faye Anderson, Karen Frith, Fan Tseng, Mikel Petty and Gregory Reed have done.
Researchers in the United States have analyzed the neutralizing activity of Moderna's mRNA-1273 vaccine against several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 9 days ago
Entity Name | Radiation Oncology Group Consultants P C |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396714515 PECOS PAC ID: 0446248405 Enrollment ID: O20040506000397 |
News Archive
Idera Pharmaceuticals, Inc. today announced the publication of data from studies of a dual agonist of Toll-like Receptor 7 and TLR8 in preclinical models of cancer. The Company created this first-in-class RNA-based dual agonist of TLR7 and TLR8 through its chemistry-based approach to identifying novel TLR-targeted drug candidates.
Piramal's Healthcare vertical today announced that it is to invest USD 2.5 million at its FDA approved Grangemouth, UK, site to upgrade one of its antibody drug conjugate (ADC) manufacturing suites, from clinical phase to commercial grade, in response to customer demand.
Worldwide, there are over 3 million stillbirths and approximately 3 million newborn deaths each year, most in low-resource countries.
Decisions, decisions, decisions. Wouldn't it be nice to have a computer program that could help you make work-related decisions? That's exactly what Drs. Faye Anderson, Karen Frith, Fan Tseng, Mikel Petty and Gregory Reed have done.
Researchers in the United States have analyzed the neutralizing activity of Moderna's mRNA-1273 vaccine against several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Grant Harmon, MD 1001 W Madison St Apt 302, Chicago, IL 60607-2099 Ph: (630) 945-7744 | Grant Harmon, MD 510 Sw Ramsey Ave, Grants Pass, OR 97527-5554 Ph: (541) 789-4673 |
News Archive
Idera Pharmaceuticals, Inc. today announced the publication of data from studies of a dual agonist of Toll-like Receptor 7 and TLR8 in preclinical models of cancer. The Company created this first-in-class RNA-based dual agonist of TLR7 and TLR8 through its chemistry-based approach to identifying novel TLR-targeted drug candidates.
Piramal's Healthcare vertical today announced that it is to invest USD 2.5 million at its FDA approved Grangemouth, UK, site to upgrade one of its antibody drug conjugate (ADC) manufacturing suites, from clinical phase to commercial grade, in response to customer demand.
Worldwide, there are over 3 million stillbirths and approximately 3 million newborn deaths each year, most in low-resource countries.
Decisions, decisions, decisions. Wouldn't it be nice to have a computer program that could help you make work-related decisions? That's exactly what Drs. Faye Anderson, Karen Frith, Fan Tseng, Mikel Petty and Gregory Reed have done.
Researchers in the United States have analyzed the neutralizing activity of Moderna's mRNA-1273 vaccine against several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 9 days ago
Marcus Alan Bryner, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 500 Ramsey Ave, Grants Pass, OR 97527 Phone: 541-472-7140 | |
Jonathan A Wood, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 500 Sw Ramsey Ave, Grants Pass, OR 97527 Phone: 541-472-7140 | |
Philip M Rose, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 500 Sw Ramsey Ave, Grants Pass, OR 97527 Phone: 541-472-7140 | |
Halil Omer Ikizler, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 500 Sw Ramsey Ave, Grants Pass, OR 97527 Phone: 541-472-7040 | |
Dr. Gary Hansen, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 500 Sw Ramsey Ave, Grants Pass, OR 97527 Phone: 541-471-4485 | |
Dr. Theodore J. Robnett, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 510 Sw Ramsey Ave, Grants Pass, OR 97527 Phone: 541-472-7040 |